Now Available at MidWest Pain Clinics

Qutenza® for the Treatment of Neuropathic Pain Associated with Diabetic Neuropathy of the Foot And post-shingles nerve pain.

The U.S. Food and Drug Administration (FDA) has approved Qutenza® (capsaicin) 8% topical system for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. And for adults whose lives are affected by post-shingles nerve pain. A single localized procedure with QUTENZA® may provide up to 3 months of pain relief. Qutenza is the first and only treatment of its kind to deliver prescription strength capsaicin directly into the skin. For post-Shingles nerve pain, the topical system is applied directly to the pain site and will provide up to 6 months of pain relief.

Physicians here at MidWest Pain Clinics are now offering Qutenza during an in-office procedure as another way to effectively treat neuropathic pain. Qutenza can desensitize and defunctionalize the TRPV1 (Transient Receptor Potential Vanilloid 1) receptor, which plays a critical role in pain signaling.

Relief with Qutenza has no known drug interactions. The most common adverse reactions are erythema (skin redness), pain, and pruritus (itching) at the application site. The majority of these reactions are transient. Qutenza® (capsaicin) 8% topical system was approved in the U.S. for the management of neuropathic pain associated with postherpetic neuralgia in 2009; the FDA approved it for the management of neuropathic pain associated with diabetic peripheral neuropathy pain associated on July 21, 2020. Qutenza is manufactured by Averitas Pharma.

For an appointment with a provider trained in the application of Qutenza, please call the MidWest Pain Clinics at 402-391-7246.


Qutenza, used for the treatment of neuropathic pain associated with diabetic neuropathy of the foot and post-shingles nerve pain now available at MidWest Pain Clinics. Continue reading below for more information about the treatment as well as facts about neuropathic pain associated with diabetic peripheral neuropathy, Or post-shingles nerve pain. CLICK HERE to contact us to schedule an appointment and discuss the use of Qutenza for your neuropathic pain.

January 12, 2021

Qutenza: Treatment of Neuropathic Pain – Now Available at MidWest Pain Clinics

Now Available at MidWest Pain Clinics Qutenza® for the Treatment of Neuropathic Pain Associated with Diabetic Neuropathy of the Foot And post-shingles nerve pain. The U.S. […]
May 7, 2020

Knee Pain Q & A

Why does my knee hurt? Knee pain can occur after a specific injury or may be related to wear-and-tear over a number of years. Common types […]
April 17, 2020

Sciatica Q & A

What is sciatica? Sciatica is a condition that causes inflammation of the sciatic nerve in your lower back. This nerve travels from your lower back, through […]
March 19, 2020

Statement Regarding COVID-19 (Coronavirus)

Multiple states have confirmed cases of COVID-19 (Corona Virus), our top priority at Midwest Pain Clinics/Omaha Ambulatory Surgical Center is to keep our patients and staff […]
Call Us
Our Location